There is no doubt that patients who continue maintenance Revlimid (lenalidomide) following autologous transplant do better than those who do not. Dr. Phil McCarthy showed unequivocally in CALGB 100104 (Revlimid vs placebo) that progression free survival (PFS) and overall survival (OS) are longer for patients taking maintenance Revlimid. Likewise, maintenance therapy extends PFS for patients […]
Attending the ASH IMF Satellite Symposium, “Accelerating Toward Curing Myeloma: New Data, New Agents, and Evolving Treatment Paradigm,” on Friday afternoon reminded me once again why I enjoy attending ASH. Primarily because it gives me hope: Hope in knowing that the experts are working so hard to find the best treatment, hope in seeing the […]
Minimal Residual Disease (-) (meaning no detectable disease) has become the agreed goal of most myeloma clinical trials. MRD (-) status is a predictor of good outcome. As we patients progress with treatment we want to know if we have reached MRD (-) or not, however it is defined, and by whichever method it is measured. […]
The American Society of Hematology’s Annual Meeting (ASH) has just begun, but thanks to the pre-ASH Scientific Workshops, On-Demand Sessions, and Satellite Symposia, my head is already spinning. Much of what I heard in the scientific workshops was above my head, but provided me with hope. Each year when I attend ASH, I leave thinking, […]
The life expectancy of standard-risk myeloma patients has increased significantly in the last decade, thanks to novel therapies. Some trials that are in progress, such as the MAIA trial comparing Revilmid and dexamethasone (Rd) versus Daratumumab, Revilmid and dexamethasone (DRd) have not yet met their progression-free survival (PFS) end state and are at more than […]
I find it hard to believe it’s December, let alone The 62nd American Society of Hematology Annual Meeting (ASH). I extend my heartfelt gratitude to the International Myeloma Foundation (IMF) and their sponsors for the opportunity to attend as part of the IMF ASH Team. I think we can all agree that 2020 has […]
What a year we have endured! 2020 will be one of the darkest years in history for the USA ,similar to the turmoil and strife of 1968, an unforgettable year those of us old enough to remember it. Actually, our comparator for “worst year” must go back further than 1968; however, to a time none of […]
